Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with CVD and either obesity or overweight, John Sharretts, MD, director of the division of diabetes, lipid disorders and obesity in the FDAs Center for Drug Evaluation and Research, said in the statement
Van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WHM
Step-by-step injection training plus a simple dosing plan so you know exactly what to take and when
For timing specifically, our retatrutide results timeline explains when early effects, 24-week results, and longer TRIUMPH endpoints start to matter
Always work with your healthcare provider to design a tapering schedule matched to your health history, medications, and metabolic needs
The triple-action mechanism might require different dose adjustments compared to dual agonists